<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dias BT</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Medical Research Council</funding><funding>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</funding><pagination>10794-10807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6766642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(10)</volume><pubmed_abstract>Visceral leishmaniasis is a deadly illness caused by &lt;i>Leishmania donovani&lt;/i> that provokes liver and spleen inflammation and tissue destruction. In cutaneous leishmaniasis, the protein of &lt;i>L. major&lt;/i>, named inhibitor of serine peptidases (ISP) 2, inactivates neutrophil elastase (NE) present at the macrophage surface, resulting in blockade of TLR4 activation, prevention of TNF-α and IFN-β production, and parasite survival. We report poor intracellular growth of &lt;i>L. donovani&lt;/i> in macrophages from knockout mice for NE (&lt;i>ela&lt;/i>&lt;sup>-/-&lt;/sup>), TLR4, or TLR2. NE and TLR4 colocalized with the parasite in the parasitophorous vacuole. Parasite load in the liver and spleen of &lt;i>ela&lt;/i>&lt;sup>-/-&lt;/sup> mice were reduced and accompanied by increased NO and decreased TGF-β production. Exp</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>Neutrophil elastase promotes &lt;i>Leishmania donovani&lt;/i> infection &lt;i>via&lt;/i> interferon-β.</pubmed_title><pmcid>PMC6766642</pmcid><funding_grant_id>MR/N017269/1</funding_grant_id><funding_grant_id>MR/P027989/1</funding_grant_id><pubmed_authors>Mukhtar MM</pubmed_authors><pubmed_authors>Godinho JP</pubmed_authors><pubmed_authors>Mottram JC</pubmed_authors><pubmed_authors>Lima APCA</pubmed_authors><pubmed_authors>Calegari-Silva T</pubmed_authors><pubmed_authors>Dias BT</pubmed_authors><pubmed_authors>Faria MS</pubmed_authors><pubmed_authors>Dias-Teixeira KL</pubmed_authors><pubmed_authors>Lopes U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neutrophil elastase promotes &lt;i>Leishmania donovani&lt;/i> infection &lt;i>via&lt;/i> interferon-β.</name><description>Visceral leishmaniasis is a deadly illness caused by &lt;i>Leishmania donovani&lt;/i> that provokes liver and spleen inflammation and tissue destruction. In cutaneous leishmaniasis, the protein of &lt;i>L. major&lt;/i>, named inhibitor of serine peptidases (ISP) 2, inactivates neutrophil elastase (NE) present at the macrophage surface, resulting in blockade of TLR4 activation, prevention of TNF-α and IFN-β production, and parasite survival. We report poor intracellular growth of &lt;i>L. donovani&lt;/i> in macrophages from knockout mice for NE (&lt;i>ela&lt;/i>&lt;sup>-/-&lt;/sup>), TLR4, or TLR2. NE and TLR4 colocalized with the parasite in the parasitophorous vacuole. Parasite load in the liver and spleen of &lt;i>ela&lt;/i>&lt;sup>-/-&lt;/sup> mice were reduced and accompanied by increased NO and decreased TGF-β production. Exp</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-21T23:28:05.406Z</modification><creation>2019-10-11T07:12:51Z</creation></dates><accession>S-EPMC6766642</accession><cross_references><pubmed>31284755</pubmed><doi>10.1096/fj.201900524R</doi></cross_references></HashMap>